Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1409 results about "Signal Pathways" patented technology

Quinazoline stilbene derivative as well as preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly relates to quinazoline stilbene derivatives as well as a preparation method, a composition and application thereof. The quinazoline stilbene derivative is synthesized by combining quinazoline with pharmacophores such as a styrene skeleton, and the quinazoline stilbene derivative structurally contains functional units such as a quinazoline functional unit and the pharmacophores such as the styrene skeleton, so that the compound is endowed with good anti-tumor activity. Researches show that the quinazoline stilbene derivative has a good anti-tumor effect including KRASG12C mutation non-small cell lung cancer, has the advantage of multi-target action, has an adjusting effect on Src kinase and related downstream signal channels of Statat, mTOR, Akt and PI3k, and is beneficial to reduction of tumor drug resistance. Compared with a complex structure modified compound, the quinazoline stilbene derivative disclosed by the invention is simple in structure and easy to prepare, and has a good application prospect.
Owner:OCEAN UNIV OF CHINA

New substituted heterocyclic compound as gspts / MYC signal flux regulator

Disclosed in the present invention is a new substituted heterocyclic compound having GSPT1 degradation activity, and particularly disclosed is a compound having the structure as shown in formula (I) as a GSPT1 degradation agent, or a pharmaceutically acceptable salt, a solvate, a hydrate, an isotope substitute or an isomer thereof. The compound can be used for preventing or treating diseases related to GSPTs / MYC targets or signaling pathways.
Owner:MINDRANK AI LTD +1

Application of ganoderma lucidum exosome in treatment of brain glioma, extraction method and composition

The invention relates to the technical field of biological products, and provides an application of a ganoderma lucidum exosome in treatment of brain glioma, an extraction method and a composition, and the application of the ganoderma lucidum exosome in any one or more of the following applications: a) preparing a product for promoting apoptosis of brain glioma cells; b) preparing a product for inhibiting brain glioma cell proliferation; c) preparing a product for inhibiting autophagy of brain glioma cells; and d) preparing a product for treating the brain glioma. It is verified through cell and animal experiments that the ganoderma lucidum exosome can effectively induce apoptosis of the brain glioma cells and inhibit autophagy of the brain glioma cells to induce death of the brain glioma cells, and acts on the brain glioma cells through an AKT / mTOR signal channel and inhibition of generation of autophagosome of the brain glioma cells.
Owner:LIAOCHENG PEOPLES HOSPITAL

Synergistic nano-drug for removing fibrosis and inhibiting pancreatic cancer metastasis and preparation method of nano-drug

The invention belongs to the field of pharmaceutical preparations, and particularly discloses a synergistic nano-drug for understanding fibrosis and inhibiting pancreatic cancer metastasis and a preparation method of the synergistic nano-drug, excipient-related toxicity is avoided through self-assembly of small-molecule prodrugs, the drug loading rate is high, homologous targeting and receptor protein-mediated active targeting on fibrotic adhesion interstitial substances are achieved through coating of a hybrid membrane, and the nano-drug has the advantages of being high in bioavailability, high in bioavailability and the like. Through the response of prodrug molecules to ROS, massive, rapid and traceless drug release in fibrotic adhesion interstitial substances is realized, and the self-limiting characteristic of release of responsive micromolecular drugs is relieved; the released medicines Cap and CA can inhibit fibrosis signals / proteins at the same time and synergistically defibration; along with the proceeding of defibrosis, Cap and CA which are rapidly and seamlessly released in pancreatic cancer cells can simultaneously inhibit a metastasis / invasion signal channel of the pancreatic cancer cells and synergistically inhibit the occurrence of metastasis; the defibration process and the metastasis inhibition process are dynamically coordinated, and a new way is provided for defibration in pancreatic cancer treatment.
Owner:LINGNAN NORMAL UNIV

Heart organoid and in-vitro preparation method thereof

The invention relates to a heart organoid and an in-vitro preparation method thereof, and belongs to the technical field of stem cells. The invention provides a heart organoid. The heart organoid is obtained by induced culture of an adherent pluripotent stem cell mass; the adherent pluripotent stem cell mass is obtained by adherent culture of a suspended pluripotent stem cell mass; the suspension pluripotent stem cell mass is obtained by suspension culture of pluripotent stem cells. According to the in-vitro preparation process of the heart organoid, after pluripotent stem cells form balls, the pluripotent stem cell balls are subjected to staged induced differentiation under adherent culture, so that cell subtypes such as epicardial cells and the like can be generated without additional addition or additional stimulation of signal channels, and the heart organoid is more homogeneous. The self-occurring multi-lineage coexisting heart organoid can better simulate biological events derived from multiple cell types and multiple cell subtypes in the early development process of an embryonic heart, and has great application prospects in exploration of pathogenic factors and potential treatment targets of congenital heart diseases.
Owner:NANJING MEDICAL UNIV +1

Clostridium praeparatum microbial anti-inflammatory molecule as well as screening method and application thereof

The invention relates to the technical field of biology, in particular to a clostridium praeparatum microbial anti-inflammatory molecule as well as a screening method and application of the clostridium praeparatum microbial anti-inflammatory molecule. The amino acid sequence of the clostridium praeparatum microbial anti-inflammatory molecule is shown as (a) or (b); (a) the amino acid sequence is as shown in SEQ ID NO.1; and (b) a protein which is derived from (a), has anti-inflammatory activity and is obtained by substituting, deleting or adding one or more amino acids to the amino acid sequence in (a). Compared with a microbial anti-inflammatory molecular protein of a representative strain A2-165 of a Faecalibacterium genus, the inhibition effects of the microbial anti-inflammatory molecular protein on an NF-kB signal channel and an inflammatory factor TNF alpha are 50% and 56% respectively, while the anti-inflammatory effect (inhibiting the NF-kB signal channel) of the clostridium praeparatum microbial anti-inflammatory molecule screened by the application can reach 90% or above, and the clostridium praeparatum microbial anti-inflammatory molecule has the advantages of small dosage and strong anti-inflammatory effect.
Owner:GUANGZHOU FIRST PEOPLES HOSPITAL (GUANGZHOU DIGESTIVE DISEASE CENT GUANGZHOU FIRST PEOPLES HOSPITAL GUANGZHOU MEDICAL UNIV THE SECOND AFFILIATED HOSPITAL OF SOUTH CHINA UNIV OF TECH)

Rice cytokinin response regulatory factor gene OsRR24 and application thereof

The invention belongs to the technical field of plant genetic engineering, and particularly relates to a rice cytokinin response regulatory factor gene OsRR24 and application thereof.The rice cytokinin response regulatory factor gene OsRR24 encodes a protein containing a DNA binding structural domain and a conservative signal receiving structural domain containing aspartic acid; the gene is a response regulatory factor at the downstream of a rice CK signal pathway. In the process of researching the function of the OsRR24 in the rice, the OsRR24 is respectively transferred into Nipponbare and Bph6-NIL through agrobacterium-mediated genetic transformation, the resistance of overexpressed plants to brown planthoppers is remarkably enhanced, and the resistance of RNAi inhibited plants to the brown planthoppers is remarkably weakened. The gene provided by the invention provides a good theoretical basis for researching how cytokinin participates in rice insect-resistant reaction through response regulatory factors, has reference significance for researching gene molecular functions, and also provides gene resources for rice insect-resistant molecular design and breeding.
Owner:HUAZHONG AGRI UNIV

Medicine for treating Alzheimer's disease and preparation method thereof

The invention provides a medicine for treating Alzheimer's disease and a preparation method thereof, and belongs to the technical field of biological medicine. The active ingredients of the traditional Chinese medicine composition comprise prepared rhizoma polygonati extract, semen cassiae extract and ligusticum wallichii extract. Experimental research is carried out by taking caenorhabditis elegans as a research object, and the result shows that (1) the traditional Chinese medicine composition can improve the life vitality of the caenorhabditis elegans and improve the vital signs of senescent caenorhabditis elegans; (2) the mitochondrial function can be adjusted, the dense form of mitochondria can be kept, the ATP content can be adjusted, the mitochondrial respiratory chain can be enhanced, the mitochondrial movement can be continuously promoted, the mitochondrial unfolded protein reaction can be promoted, and the endoplasmic reticulum stress can be inhibited; (3) the anti-oxidation effect is achieved; (4) the action mechanism on nematodes comprises a plurality of AD-related signal channels, and a multi-channel multi-target effect is achieved; and (5) the effect of the traditional Chinese medicine composition on the Alzheimer's disease is the additive effect of the main compound of the traditional Chinese medicine composition to a certain extent.
Owner:HANGZHOU NORMAL UNIVERSITY +1

Composition with longevity gene activation effect

The invention belongs to the field of daily chemicals, and provides a composition with a longevity gene activation effect, a product containing the composition and application of the composition, and the composition provided by the invention comprises hexapeptide, chlamydomonas and cornflower extract. The hexapeptide, the chlamydomonas nivalis and the cornflower extract are compounded for use, so that the expression of longevity genes KLOTHO and SIRT1 can be remarkably improved. Once the longevity gene serving as the upstream of a signal regulation pathway is activated, various downstream signal pathways can be regulated, such as inhibition of expression of inflammation-related genes, promotion of DNA repair, telomere homeostasis, gene expression of mitochondrial energy and the like, promotion of synthesis of collagen and the like, and finally, longevity of cells and improvement of skin phenotypes are promoted. The effects of resisting wrinkles, tightening and the like are achieved. Therefore, the composition provided by the invention can activate long-life gene expression and regulate and control multiple signal pathways, has potential effects of improving light aging, tightening and resisting wrinkles and the like, and is an anti-aging composition with great potential.
Owner:GUANGZHOU JIYAN COSMETICS TECH CO LTD

Manganese-doped zeolite imidazole framework and application thereof in tumor radiotherapy

The invention belongs to the technical field of biological medicine, and particularly relates to a manganese-doped zeolite imidazole framework and application thereof in tumor radiotherapy. According to the present invention, the new use of the manganese-doped zeolite imidazole framework as the tumor radiosensitizer is found, Mn-ZIF-8 has ray responsiveness, can continuously release Mn < 2 + > ions under X-ray irradiation, and can enhance the activation of a cGAS-STING signal channel so as to promote DCs maturation and antigen presentation, and enhance the T cell mediated immune response, such that the tumor treatment effect is enhanced. Furthermore, the invention provides the Mn-ZIF-8 microneedle, the microneedle has the characteristics of rapid dissolution and controlled release, ensures accurate delivery and continuous action of drugs at tumor sites, reduces systemic toxicity, and can significantly amplify local and systemic immune effects caused by radiotherapy and improve the therapeutic effect when used in combination with an immune checkpoint inhibitor.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Core-shell structure drug-loaded magnetic-thermal hydrogel microsphere for treating drug-resistant ovarian cancer and preparation method thereof

The invention relates to a core-shell structure drug-loaded magnetic-thermal hydrogel microsphere for treating drug-resistant ovarian cancer and a preparation method thereof, belonging to the field of biological and medical micro-nano materials and technologies, and the core-shell structure drug-loaded magnetic-thermal hydrogel microsphere is formed by combining an inner core and a shell layer through covalent crosslinking and electrostatic interaction. An anti-tumor drug cis-platinum and magnetic nanoparticles are loaded on an inner core, and an AZ191 inhibitor is loaded on a chitosan shell, so that preferential release of AZ191 is realized to inhibit a drug-resistant signal channel and reduce the drug resistance of cancer cells, and the cis-platinum is slowly released after the action is completed to kill tumor cells. And the magnetic nanoparticles in the inner core can be heated under an external magnetic field, so that multifunctional synergistic treatment of magnetic hyperthermia, drug resistance inhibition and chemotherapy is realized. Chitosan and sodium alginate are biodegradable materials, so that the utilization rate of the embedded medicine can be increased, and meanwhile, the medicine can be metabolized out of a body. The preparation method does not relate to toxic cross-linking agents and organic solvents, and the prepared hydrogel core-shell microspheres have no biotoxicity. Complicated operation steps are not needed, the technological process is simple, the preparation period is short, and the application range is wide.
Owner:DALIAN UNIV OF TECH

Bird's nest and anti-aging factor composite formula and processing technology thereof

The invention relates to the technical field of cubilose formulas, in particular to a cubilose and anti-aging factor composite formula and a processing technology thereof. The composition can improve hydration of skin, enhance elasticity, slow down aging signs, help to resist damage of free radicals, protect cells from oxidative pressure, contribute to enhancing an immune system and improving body resistance, is easy to absorb, can improve intestinal health and promote nutrient absorption, and has a positive effect on recovery after exercise. The repair of muscular tissues can be facilitated; the anti-aging component disclosed by the invention is related to self-renewal and differentiation of stem cells, so that the anti-aging component plays a key role in tissue repair and regeneration, has positive influence on maintaining health and functions of the stem cells and possibly resisting aging, and can regulate a Wnt signal channel related to cell proliferation and differentiation; the aging process of the tissue is influenced by regulating and controlling the signal channels, and meanwhile, the rapid repair of the tissue can be regulated to further delay the aging effect.
Owner:广东润康药业有限公司

Application of AI-driven target screening technology in anti-obesity treatment of drug delivery system

The invention discloses application of an AI-driven target screening technology in anti-obesity treatment of a drug delivery system, and belongs to the field of cross fusion of biological medicine and artificial intelligence. The screening method provided by the invention comprises the following steps: selecting a signal channel target and active small molecules related to lipid metabolism; processing the signal channel target and the active small molecules through the data set to obtain an input matrix; and inputting the input matrix into a deep learning model to obtain the interaction intensity between the active small molecules and the signal path target. According to the method, an artificial intelligence technology is introduced, a deep learning model is constructed to efficiently predict the affinity between a drug and a protein target, the problems that a traditional target screening method depends on experience and is low in efficiency are solved, and target expression is subjected to experimental verification through a molecular biology method, so that the target screening efficiency is improved. A verification closed loop from calculation prediction to molecular demonstration is realized, and the biological credibility of a target screening result is proved.
Owner:DALIAN POLYTECHNIC UNIVERSITY

Specific membrane protein marker and membrane protein dimer simultaneous detection kit and application thereof

ActiveCN120085008ARaman scatteringBiological testingReceptorMembrane proteome
The invention belongs to the technical field of functional nanoprobes and biological detection, and particularly relates to a kit for simultaneously detecting a specific membrane protein marker and a membrane protein dimer and application of the kit. The detection kit comprises a membrane proteome anchoring chain, a recognition probe, an SERS probe and an auxiliary signal amplification reagent, by combining DNA logic sensing based on aptamer recognition and logic response type assembly based on EpCAM protein expression and DNA signal amplification of Met protein dimerization, networked assembly of a recognition probe and an SERS probe is realized, so that specific accurate recognition of tumor cells and high-sensitivity SERS detection and imaging of membrane protein dimers are realized; the method is suitable for monitoring an HGF / Met signal channel based on Met protein dimerization mediation between stromal cells and cancer cells in a complex tumor microenvironment, and can evaluate the inhibition effect of a targeted drug on receptor dimerization in real time.
Owner:NANJING UNIV OF POSTS & TELECOMM

Immune cell culture data monitoring method and system based on activation analysis

The invention relates to the technical field of immune cell culture, in particular to an immune cell culture data monitoring method and system based on activation analysis. When the immune cell culture equipment monitors that the signal protein is conducted on the abnormal standard signal channel, the real-time metabolic network is reduced based on the interference degree of the abnormal standard signal channel on the metabolic pathway, the metabolic enzyme concentration is calculated and analyzed, and a metabolic activity monitoring reference is generated; if it is monitored and detected in real time that unreasonable metabolism conditions exist in metabolic data of immune cell culture, peak integral deviation parameters for cell factor compensation are constructed based on the metabolic enzyme concentration deviation value of the metabolic activity monitoring benchmark to conduct injection compensation regulation and control on cell factors of the cultured immune cell sample. According to the method, the abnormal proliferation data, the abnormal proliferation-causing signal path data and the metabolic data in the immune cell culture process can be subjected to rapid and accurate activation analysis, so that the immune cell activation performance can be better optimized, and the culture quality is improved.
Owner:SHENZHEN ZHONGXU CELL REGENERATIVE MEDICINE RES CO LTD

Discovery method of cough-relieving and phlegm-eliminating quality marker of cough-relieving granules and quality marker

The invention relates to the technical field of traditional Chinese medicine research, in particular to a discovery method of a cough relieving and phlegm eliminating quality marker of cough relieving granules and the quality marker. According to the application, the cough-relieving and phlegm-eliminating drug effects of the cough-relieving granules are evaluated by virtue of concentrated ammonia water cough inducing and phenol red excretion tests, plasma pharmaceutical chemistry research of the cough-relieving granules is developed by virtue of a UHPLC-Q-Exactive Plus Orbitrap HRMS technology, and 26 prototype blood-entering components of the cough-relieving granules are analyzed and identified; through network pharmacological analysis of components entering blood, 11 potential active components for relieving cough and eliminating phlegm of the cough-relieving granules are screened, relate to 40 common targets such as IL6, TLR4, STAT3 and the like, and mainly participate in signal channels such as PI3K-Akt, HIF-1, EGFR (epidermal growth factor receptor) and the like; the seven prototype blood-entering components are quantitatively analyzed by utilizing pharmacokinetics. The three compounds of azelaic acid, caffeic acid and vanillin are used as the cough relieving and phlegm eliminating quality markers of the cough relieving granules through effectiveness, transitivity and testability. The research result is of great significance in deeply defining the pharmacodynamic material basis of the cough-relieving granules, optimizing the quality standard and promoting the clinical application of the cough-relieving granules.
Owner:GUIZHOU DALONG PHARM CO LTD

Application of rice OsPBL8 gene in enhancing resistance of rice to magnaporthe oryzae

The invention relates to the technical field of biology, in particular to application of a rice OsPBL8 gene in enhancing resistance of rice to magnaporthe oryzae. The rice OsPBL8 gene is a rice endogenous gene participating in the processes of plant growth and development, abiotic stress response, hormone signal channel regulation and control and the like. The invention provides application of the OsPBL8 gene in the field of disease resistance, the OsPBL8 gene is overexpressed through gene editing, and the expression quantity of receptor-like cytoplasm kinase OsPBL8 in plants is increased, so that a plurality of signal channels are regulated and controlled, and the germ resistance of the plants is synergistically improved. By adjusting key hub nodes of plant targeted immune signal transduction, more lasting broad-spectrum disease resistance can be provided, good universality is achieved, disease resistance and growth can be balanced, good practicability is achieved, and improvement of disease resistance of various rice varieties is facilitated.
Owner:SUZHOU UNIV

Preparation method of polygonatum sibiricum polysaccharide and application of polygonatum sibiricum polysaccharide in slow-transit constipation medicine

The invention relates to a preparation method of polygonatum sibiricum polysaccharide and application of the polygonatum sibiricum polysaccharide in a slow-transit constipation medicine, a polygonatum sibiricum raw medicinal material is used as a raw material, polygonatum sibiricum crude polysaccharide (PCP) is extracted through a water extraction and alcohol precipitation method, and a polygonatum sibiricum neutral polysaccharide homogeneous component PCNP-2 is prepared after purification. The prepared PCNP-2 has the effects of regulating intestinal flora, reducing intestinal permeability and improving lipid metabolism, is helpful for relieving gastrointestinal inflammation, diabetes and other diseases, and can be made into effective and safe STC treatment drugs. The medicine effect of the PCNP-2 can be achieved through a PI3K / AKT signal channel, and the intestinal motility weakening phenomenon of a slow transit constipation mouse model is remarkably reversed through treatment of the polygonatum polysaccharide PCNP-2.
Owner:TIANJIN MEDICAL UNIVERSITY GENERAL HOSPITAL +1

Application of LECT2 as diagnosis and treatment target of hepatic ischemia reperfusion injury

The invention discloses application of LECT2 as a diagnosis and treatment target of hepatic ischemia reperfusion injury. According to the present invention, the Print method operation patient sample is detected to discover that the expression of the LECT2 in the hepatic ischemia reperfusion injury is up-regulated; on the basis, a liver ischemia reperfusion injury model is constructed by knocking out a mouse through the LECT2 gene, and a result shows that the liver ischemia reperfusion injury of the mouse is obviously reduced by knocking out the LECT2 gene and transferring the LECT2-shRNA into the LECT2 gene, and the liver ischemia reperfusion injury of the mouse is aggravated by LECT2 recombinant protein; it is shown that inhibition of expression of LECT2 is beneficial to improvement or treatment of hepatic ischemia injury; furthermore, the invention further finds that liver injury can be relieved by inhibiting the combination of LECT2 and Tie1; the LECT2 / Tie1 signal channel can also be used as a target spot for treating the liver ischemia reperfusion injury.
Owner:SOUTHERN MEDICAL UNIVERSITY

Application of dsRNA in inhibition of reproductive capacity of bemisia tabaci

The invention provides application of dsRNA in inhibition of reproductive capacity of bemisia tabaci, and belongs to the technical field of pesticides. The dsRNA is one or more of dsBtInR1 and dsBtInR2, and the dsRNA is one or more of dsBtInR1 and dsBtInR2. According to the invention, two bemisia tabaci insulin receptor genes BtInR1 and BtInR2 are found, and after the expression levels of BtInR1 and BtInR2 in bemisia tabaci are knocked down, a JH signal channel can be influenced by interfering an insulin signal channel, and finally, the reproductive capacity of the bemisia tabaci is inhibited, so that a theoretical and application basis is provided for developing and producing green biopesticide for preventing and treating the bemisia tabaci.
Owner:QINGDAO AGRI UNIV

VEGF / TIE-2 dual-targeting polypeptide and application thereof in preparation of antitumor drugs

The invention discloses a VEGF / TIE-2 dual-targeting polypeptide and application thereof in preparation of antitumor drugs, and relates to the technical field of biological medicines. The VEGF / TIE-2 dual-targeting polypeptide (named as RTP) provided by the invention is formed by combining an amino acid sequence capable of identifying VEGF and TIE-2 in a targeting manner, an amino acid sequence capable of forming beta-sheet nanofibers through self-assembly, an amino acid sequence capable of identifying carbonic anhydrase IX in a targeting manner and an enzyme reactive amino acid sequence capable of realizing MMP-2 specific shearing. The RTP can be subjected to allosteric and self-assembly in tumor cells to form stable water-insoluble nanofibers, the formation and metastasis of tumor neovascularization are strongly inhibited through VEGF and TIE-2 double signal channels, and the tumor progress is inhibited.
Owner:HARBIN MEDICAL UNIVERSITY

Double-target chimeric antigen receptor co-expressing CD47 and IL-15, CAR-T cell and application of CAR-T cell

The invention discloses a double-target chimeric antigen receptor for co-expression of CD47 and IL-15, a CAR-T cell and application of the CAR-T cell, and belongs to the technical field of genetic engineering, the double-target chimeric antigen receptor comprises a single-chain antibody scFv-EGFRv III, a single-chain antibody scFv-VEGF, CD47 and IL-15; the nucleotide artificial sequence of the single-chain antibody scFv-EGFRv III is as shown in SEQ ID NO. 6; the nucleotide artificial sequence of the single-chain antibody scFv-VEGF is as shown in SEQ ID NO. 9. According to the application disclosed by the invention, by performing sequence optimization on targets EGFRvIII and VEGF, the anti-tumor effect of CAR-T cells in glioblastoma can be improved, and by integrating immune checkpoint molecules CD47 and interleukin-15, the immunosuppression function of a CD47-SIRP alpha signal channel can be locally exerted.
Owner:SHANGHAI XINGRUIYIDA BIOTECHNOLOGY CO LTD

Small peptide for improving abiotic stress tolerance of crops and application thereof

The invention belongs to the technical field of biotechnology and botany, and particularly relates to a small peptide for improving abiotic stress tolerance of crops and application of the small peptide, and the small peptide is GhIDL02 and / or GhPIPL7. The amino acid sequence of the GhIDL02 is as shown in SEQ ID NO. 1; the amino acid sequence of the GhPIPL7 is as shown in SEQ ID NO. 2. According to the method, the small peptide GhIDL02 or GhPIPL7 is exogenously applied, so that the hormone-like effect is quickly exerted, the salt tolerance of the cotton is remarkably improved, and the adverse effect of a chemical regulating agent on the environment is avoided. Through a research technology combining bioinformatics and molecular biology, the positive regulation effect of the GhIDL02 and GhPIPL7 small peptides under salt stress is confirmed for the first time, and by activating an MAPK signal channel, the steady state of cotton sodium and potassium ions is maintained, the salt tolerance of cotton is improved, and a theoretical basis and technical support are provided for green development of an agricultural biotechnology.
Owner:XINJIANG UNIVERSITY

System and method for verifying agent receiving module with SPC in chip

The invention relates to a system and a method for verifying a current receiving module with an SPC in a chip, and the system comprises the steps: constructing a new verification system composed of an SPC controller, a current transmitting assembly, a to-be-tested design and two buf1 assemblies, and controlling a signal path between the SPC controller and a microcontroller, and a signal path between the current transmitting assembly and the microcontroller through the two buf1 assemblies, thereby achieving the verification of the current receiving module with the SPC in the chip. In the EDA verification stage, the current receiving module with the SPC function can be verified, so that the verification of the current receiving module with the SPC function does not need to be realized at a hardware level. Meanwhile, the verification technology can be well compatible with other existing whole chip verification platforms and a traditional tent receiving module verification platform, has good flexibility and reusability, and can greatly improve the verification efficiency.
Owner:上海芯钛信息科技有限公司

Chimera for degrading CARD structural domain protein aggregate and application of chimera

The invention discloses a chimera for degrading a CARD structural domain protein aggregate and application of the chimera. The chimera is prepared from light-operated targeting protein and light-operated degradation protein, the light-operated targeting protein is sequentially connected by an MAVS CARD structural domain, a flexible connecting peptide and a photosensitive protein pMag; the light-controlled degradation protein is sequentially connected by a photosensitive protein nMag, a flexible connecting peptide and an RING structural domain of TRIM21. According to the application, a light-operated activated CARD-RING chimera is constructed, and when the CARTAC generates toxic and side effects or in cells with RIG-I / MDA5 signal channels abnormally activated, the activity of the CARTAC can be effectively controlled or autoimmune diseases caused by RIG-I / MDA5 abnormity can be inhibited.
Owner:TIANJIN MEDICAL UNIVERSITY GENERAL HOSPITAL

Application of Smad6 gene in promoting reprogramming of fibroblasts into stem cells

The invention discloses an application of a Smad6 gene in promoting reprogramming of fibroblasts into stem cells. According to the application, Smad2 / 3 activation is inhibited through overexpression of the Smad6 gene, and up-regulation of important transcription factors C-Myc, Nanog and Oct4 in the stem cell state is promoted to be maintained and regulated, so that fibroblasts are promoted to be reprogrammed into the stem cells. According to the method, the roe mother cell extracting solution is adopted as an inducer to induce fibroblasts to be reprogrammed into the stem cells, and the materials are low in cost, wide in source and safe. According to the application disclosed by the invention, by means of overexpression of the Smad6 gene, fibroblasts induced by a fish egg mother cell extracting solution are promoted to be reprogrammed into stem cells, expression of stem cell related genes C-Myc, Nanog and Oct4 is promoted, activation of a TGF-beta signal channel is inhibited, expression of TGF-beta signal channel related genes Smad2, Smad3 and Smad4 is regulated and controlled, and the stem cells are obtained. The efficiency of reprogramming the somatic cells into the stem cells is improved, and the application of reprogramming is greatly promoted.
Owner:920TH HOSPITAL OF THE JOINT LOGISTIC SUPPORT FORCE OF THE CHINESE PEOPLES LIBERATION ARMY

ASIC layout optimization method based on hybrid shaping programming

The invention relates to the technical field of strategy optimization, in particular to an ASIC (Application Specific Integrated Circuit) layout optimization method based on hybrid shaping programming, which comprises the following steps of: analyzing a circuit netlist, and establishing a signal path physical model containing static topological connectivity; a candidate layout scheme is generated based on the model, and layout state data describing the state of the candidate layout scheme is generated through physical effect simulation; based on the layout state data, calculating a signal processing performance index and a wiring cost value, and generating a group of dynamic shaping constraints for guiding subsequent layout according to the index and the cost value, the dynamic shaping constraints being quantitative adjustment of a path congestion perception graph in a signal path physical model; and updating the model through the constraint, evaluating the stability of a Pareto optimal boundary formed by the performance index and the cost value so as to judge convergence, and finally outputting a layout scheme associated with a stable state. According to the method, dynamic shaping constraints are generated through a strategy optimization algorithm, and global collaborative optimization of multiple targets such as time sequence and wiring performance is achieved.
Owner:JIANGSU JULI TECHNOLOGY CO LTD

Liver-protecting active peptide as well as preparation method and application thereof

PendingCN121086004APeptide/protein ingredientsDigestive systemLiver enzyme levelsKEAP1
The invention belongs to the technical field of protein, and relates to a peptide with liver protection activity and a preparation method and application thereof, and the amino acid sequence of the peptide is PFPRPQP. The active peptide can be used for activating a Keap1 / Nrf2 signal channel by reducing the liver enzyme level and inhibiting CYP2E1 expression so as to play a role in protecting HepG2 damaged cells. The invention also provides a preparation method and application of the liver-protecting active peptide.
Owner:BEIJING TECH & BUSINESS UNIV

Traditional Chinese medicine composition, preparation method thereof and application of traditional Chinese medicine composition in preparation of medicine for preventing and treating stress insomnia

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition, a preparation method thereof and application of the traditional Chinese medicine composition in preparation of medicines for preventing and treating stress insomnia. The composition provided by the invention is composed of vinegar-processed rhizoma cyperi, green tangerine peel, pinellia ternate, poria with hostwood, salvia miltiorrhiza, ginseng, rhizoma acori graminei, nacre mother of pearl, crude dragon bone and ginger, and the comprehensive advantages of the composition in treatment of stress insomnia are shown through a multi-target and multi-channel regulation mechanism in combination with significant regulation effects of GO function enrichment and KEGG signal channels. The multi-layer action mechanism provides a unique treatment potential for the formula, and particularly has an important clinical application prospect in the aspect of coping with complex stress response and nerve dysfunction.
Owner:THE SIXTH MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL

Pharmaceutical composition containing NK cells and application of pharmaceutical composition in preparation of antitumor drugs

The invention discloses an engineered NK cell and a preparation method thereof. The antitumor activity of the NK cell is enhanced through synergistic modification of a fusion polypeptide and an anti-TIGIT monoclonal antibody. The amino acid sequence of the fusion polypeptide is shown as SEQ ID NO.1. The fusion polypeptide can specifically target tumor cells and activate the proliferation and killing functions of NK cells. And the anti-TIGIT monoclonal antibody further relieves the immunosuppression by blocking a TIGIT-CD155 signal channel. In-vitro experiments show that the killing rate of the combined modified NK cell on various solid tumors is obviously higher than that of the traditional CAR-NK cell. A PDX model shows that the engineered NK cells significantly inhibit tumor growth and enhance NK cell infiltration in a tumor microenvironment. The invention provides a new strategy with high efficiency and low toxicity for immunotherapy of solid tumors.
Owner:GUANGZHOU JINMAI BIOMEDICAL TECHNOLOGY CO LTD